- Resource
- BR1DGE
- Early Detection
- Monitoring
- Management
- Video
Education and Psychosocial Support After T1D Diagnosis – ATTD 2026
The video discusses the management of patient anxiety after positive T1D islet autoantibody results: Guidance on monitoring, education, and psychosocial support.
Learning Objectives
- Recognize the impact of a positive T1D islet autoantibody result on patients and families
- Understand the role of structured monitoring visits in managing uncertainty following positive screening results
- Apply strategies to reduce anxiety in individuals navigating early-stage T1D
Summary
At ATTD 2026, Dr Alice Cheng, Dr Jessica Melin, and Prof Karin Lange explore how to support patients and families following a positive islet autoantibody result. Experts discuss strategies for managing the initial sense of overwhelm, including reassurance around monitoring frequency and the value of an early structured review visit. Addressing anxiety about future progression is central, with a focus on breaking down concerns related to everyday life and long-term management into concrete, manageable steps.
MAT-GLB-2601654 - 1.0 - 04/2026
Technology Advances and the Persistent Burden of T1D – ATTD 2026
The video discusses how advances in insulin delivery have yet to translate into improved population-level glycemic outcomes
The Growing Global Burden of T1D
The video discusses the rising T1D burden: Adult-onset misclassification, familial risk, and autoimmune comorbidities impacting diagnosis and management.
Type 1 Diabetes in Adults
Dr Jeremy Pettus explains how to identify type 1 diabetes (T1D) in adults, avoid misclassification as type 2 diabetes (T2D), and interpret islet autoantibodies (IAbs) and C-peptide to support diagnosis and staging.